menu
    • menu

    Company profile for Xortx Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    XORTX Therapeutics Inc. is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. XORTX has lead programs to develop treatments for progressive kidney disease due to diabetes, diabetic nephropathy and polycystic kidney disease with secondary programs focused on developing therapies for health consequences that accompany pre-diabetes, diabetes and cardiovascular disease. At X...
    XORTX Therapeutics Inc. is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. XORTX has lead programs to develop treatments for progressive kidney disease due to diabetes, diabetic nephropathy and polycystic kidney disease with secondary programs focused on developing therapies for health consequences that accompany pre-diabetes, diabetes and cardiovascular disease. At XORTX Therapeutics, we are dedicated to developing medications to improve the quality of life and future health of patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Xortx TherapeuticsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    4000, 421 ? 7th Avenue SW Calgary, Alberta T2P 4K9
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.xortx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    XORTX Announces Closing of US$1.1 M Registered Direct Offering
    XORTX Announces Closing of US$1.1 M Registered Direct Offering

    29 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/29/3176264/0/en/XORTX-Announces-Closing-of-US-1-1-Million-Registered-Direct-Offering.html

    GLOBENEWSWIRE
    29 Oct 2025
    Share Share
    XORTX Prices $1.1M Registered Direct Offering
    XORTX Prices $1.1M Registered Direct Offering

    21 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/21/3170099/0/en/XORTX-Announces-Pricing-of-US-1-1-Million-Registered-Direct-Offering.html

    GLOBENEWSWIRE
    21 Oct 2025
    Share Share
    XORTX Issues Correction Notice And Extends Nasdaq Bid Price
    XORTX Issues Correction Notice And Extends Nasdaq Bid Price

    20 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/21/3169889/0/en/XORTX-Issues-Correction-Notice-and-XORTX-Announces-180-Day-Extension-to-Regain-Compliance-with-Nasdaq-Minimum-Bid-Price-Deficiency.html

    GLOBENEWSWIRE
    20 Oct 2025
    Share Share
    XORTX Acquires Renal Anti-Fibrotic Program From Vectus Biosystems
    XORTX Acquires Renal Anti-Fibrotic Program From Vectus Biosystems

    17 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/17/3168534/0/en/XORTX-Announces-Acquisition-of-Renal-Anti-Fibrotic-Therapeutic-Program-from-Vectus-Biosystems.html

    GLOBENEWSWIRE
    17 Oct 2025
    Share Share
    XORTX Hosts Live Investor Webinar on September 10
    XORTX Hosts Live Investor Webinar on September 10

    04 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/04/3144330/0/en/Join-XORTX-for-an-Exclusive-Live-Investor-Webinar-and-Q-A-Session-on-September-10.html

    GLOBENEWSWIRE
    04 Sep 2025
    Share Share
    XORTX Begins IND Prep for XORLO™ in Gout Program
    XORTX Begins IND Prep for XORLO™ in Gout Program

    03 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/03/3143437/0/en/XORTX-Initiates-IND-Preparation-for-XORLO-in-Gout-Program.html

    GLOBENEWSWIRE
    03 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search